仪器信息网 试剂标物 生化试剂 抗体/抗原 先天性脂肪代谢障碍蛋白2抗体
耗材通 9

找不到产品?留下需求帮您找

一键询价
先天性脂肪代谢障碍蛋白2抗体

先天性脂肪代谢障碍蛋白2抗体

价格: 1

品牌:康朗生物

供货周期: 现货

货号:KL6311R

规格:0.1ml/0.2ml

先天性脂肪代谢障碍蛋白2抗体Quantity size:

0.2ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Defects in BSCL2 are the cause of congenital generalized lipodystrophy type 2 (CGL2) . Congenital generalized lipodystrophy is an autosomal recessive disorder characterized by a near absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, 先天性脂肪代谢障碍蛋白2抗体hepatic steatosis and early onset of diabetes.
Defects in BSCL2 are the cause of spastic paraplegia type 17 (SPG17) ; also known as Silver spastic paraplegia syndrome. Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. SPG17 is characterized by prominent amyotrophy of the hand muscles, the presence of mild to severe pyramidal tract signs,先天性脂肪代谢障碍蛋白2抗体 and spastic paraplegia.
SPG17 is a motor neuron disease overlapping with distal spinal muscular atrophy type 5. Defects in BSCL2 are a cause of distal hereditary motor neuropathy type 5 (HMN5); also known aS distal hereditary motor neuropathy type V (DSMAV). HMN5 is an autosomal dominant disorder characterized by degeneration of motor nerve fibers, predominantly in limb distal regions.

先天性脂肪代谢障碍蛋白2抗体Also known as:

Bernardinelli Seip congenital lipodystrophy 2; Bernardinelli Seip congenital lipodystrophy type 2 protein; Bernardinelli-Seip congenital lipodystrophy type 2 protein; BSCL 2; BSCL2; BSCL2_HUMAN; GNG3LG; HMN 5; HMN5; MGC4694; Seipin; Spastic paraplegia 17 (autosomal dominant); Spastic paraplegia 17 (Silver syndrome); Spastic paraplegia 17; Spastic paraplegia with amyotrophy of hands and feet (Silver syndrome); Spastic paraplegia with amyotrophy of hands and feet; SPG 17; SPG17.

Specificity:

Rabbit Polyclonal IgG, affinity purified by Protein A.

Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, .

Immunogen: KLH conjugated synthetic peptide derived from human BSCL2/SPG17.

先天性脂肪代谢障碍蛋白2抗体Predicted Molecular Weight: 44kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl129Fi01组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)

kl129Ga01组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)

kl129Hu01组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)

kl129Mu01组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)

kl129Po01组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)

kl129Ra01组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)

kl129Rb51组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)

kl129Si01组织金属蛋白酶抑制因子3(TIMP3)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)

kl130Bo01组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)

kl130Hu01组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)

kl130Mu01组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)

kl130Po01组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)

kl130Ra01组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)

kl130Rb51组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)

kl131Bo01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Fi01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Hu01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Mu01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Po01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Rb51转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl132Hu01脂联素受体2(ADIPOR2)多克隆抗体Polyclonal Antibody to Adiponectin Receptor 2 (ADIPOR2)





生化试剂 先天性脂肪代谢障碍蛋白2抗体由上海康朗生物科技有限公司为您提供,如想了解更多关于抗体/抗原 先天性脂肪代谢障碍蛋白2抗体的报价、规格、厂家等信息,欢迎来电或留言咨询。除供应先天性脂肪代谢障碍蛋白2抗体外,上海康朗生物科技有限公司还可为您提供: β-淀粉酶,9000-91-3、 干扰素调节因子3(IRF3)重组蛋白 、 山奈酚-3-鼠李糖苷,482-39-3
推荐专场
同类试剂
该厂商试剂
相关厂商
手机版: